The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Prognosis model for overall survival in locally advanced pancreatic cancer (LAPC): An ancillary study of the LAP 07 trial.
Dewi Vernerey
No relevant relationships to disclose
Pascal Hammel
Consultant or Advisory Role - Roche
Sophie Paget-Bailly
No relevant relationships to disclose
Florence Huguet
Honoraria - Roche
Jean Luc Van Laethem
No relevant relationships to disclose
David Goldstein
No relevant relationships to disclose
Bengt Glimelius
Research Funding - Swedish Cancer Society
Pascal Artru
Consultant or Advisory Role - Amgen; Merck; Roche; Sanofi
Honoraria - Amgen; Merck; Roche; Sanofi
Malcolm Moore
Consultant or Advisory Role - Celgene
Research Funding - Celgene; ImClone Systems; Merck
Thierry André
Consultant or Advisory Role - Roche
Honoraria - Roche
Laurent Mineur
No relevant relationships to disclose
Benoit Chibaudel
No relevant relationships to disclose
Christophe Louvet
No relevant relationships to disclose
Franck Bonnetain
Consultant or Advisory Role - Bristol-Myers Squibb; Invectys; Merck; Nestle; Roche
Research Funding - Roche